Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Analgesic Reduction Study (OARS) - Pilot
NCT05283499Phase 3
Key facts
- Status
- Completed
- Start
- Jul 2020
- Primary completion
- Mar 2021
- Countries
- 1
- Sponsor
- Rutgers University
- Modality
- Small Molecules
- Conditions
- postoperative pain
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen and acetaminophen in postoperative pain (2 arms), sponsored by Rutgers University. Primary endpoint: Pain Level at 1 day. Started Jul 2020; status: completed.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Opioid Arm
Hydrocodone 5mg + Acetaminophen 350mg
Non-Opioid Arm
Ibuprofen 400mg + Acetaminophen 350mg
03
Endpoints
Primary
Pain Level
Secondary
Sleep Quality
Pain Interference Scale (PROMIS 6b)
Overall Satisfaction
Beyond the preview
Go deeper on NCT05283499.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283499.